...
首页> 外文期刊>Journal of laparoendoscopic and advanced surgical techniques, Part A >Endoscopic submucosal dissection or conventional endoscopic mucosal resection is an effective and safe treatment for rectal carcinoid tumors: a retrospective study.
【24h】

Endoscopic submucosal dissection or conventional endoscopic mucosal resection is an effective and safe treatment for rectal carcinoid tumors: a retrospective study.

机译:回顾性研究表明,内镜黏膜下剥离术或常规内镜黏膜切除术是治疗直肠类癌的一种有效且安全的方法。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Various methods for complete endoscopic resection of rectal carcinoid tumors have been reported. The aim of the present study was to evaluate the clinical usefulness of endoscopic submucosal dissection (ESD) as a new method or conventional endoscopic mucosal resection (EMR) in order to remove rectal carcinoid tumors completely. MATERIALS AND METHODS: Between April 2004 and June 2009, 12 patients with rectal carcinoid tumors, estimated at 10 mm, more or less, in diameter, without atypical features and dissected by ESD or resected by EMR, were recruited for this analysis. The complete dissection or resection rate, complications associated with the procedure, local recurrence, and distant metastases were evaluated. RESULTS: Twelve patients were 9 males and 3 females with a mean age of 47.6 years (range, 32-64). The patients had no complaints of carcinoid syndrome symptoms. Tumor size ranged from 5 to 13 mm in diameter, with an average size of 8.8 mm, and 11 of 12 patients (92.7%) had tumors of diameter less than 10 mm. Three of 12 patients (25.0%) were treated by ESD and 9 (75.0%) by conventional EMR. All lesions, including 13-mm-sized carcinoid tumors, were histologically determined to be completely dissected or resected. There were no immediate or late complications (i.e., bleeding or perforation) after ESD or conventional EMR. Histopathologically, there was no tumor invasion beyond the submucosal layer, and all were classified as classical-type carcinoids without lymphovascular invasion. Neither local recurrence nor distant metastasis were detected during a median follow-up period of 28 months. CONCLUSIONS: In this study, ESD as a new method or conventional EMR shows promise or potential as a useful, safe procedure to dissect or resect rectal carcinoid tumors of 10 mm, more or less, in diameter. However, long-term outcome remains to be elucidated by a large-scale, prospective study.
机译:背景:已报道了多种内窥镜切除直肠类癌肿瘤的方法。本研究的目的是评估内窥镜黏膜下剥离术(ESD)作为一种新方法或常规内窥镜黏膜切除术(EMR)的临床有效性,以彻底清除直肠类癌肿瘤。材料与方法:从2004年4月至2009年6月,招募了12例直肠类癌肿瘤,其直径估计为10毫米或更多或更少,无典型特征,经ESD解剖或EMR切除。评估了完整的解剖或切除率,与手术相关的并发症,局部复发和远处转移。结果:12例患者为男性9例,女性3例,平均年龄为47.6岁(范围32-64)。患者无任何类癌综合征症状的主诉。肿瘤直径范围为5到13毫米,平均直径为8.8毫米,并且12名患者中有11名(92.7%)的肿瘤直径小于10毫米。 ESD治疗的12例患者中有3例(25.0%),常规EMR的9例(75.0%)。在组织学上,所有病变,包括13毫米大小的类癌肿瘤,都被完全切除或切除。 ESD或常规EMR后无立即或晚期并发症(即出血或穿孔)。在组织病理学上,粘膜下层没有肿瘤浸润,所有肿瘤均归类为经典类癌,无淋巴管浸润。在28个月的中位随访期内,未发现局部复发或远处转移。结论:在这项研究中,ESD作为一种新方法或常规EMR,显示出有希望或有潜力作为一种有用的,安全的方法来解剖或切除直径10毫米或以上的直肠类癌。然而,长期的结果尚需通过大规模的前瞻性研究来阐明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号